Cite
Beeslaar J, Absalon J, Anderson AS, et al. MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies. Infect Dis Ther. 2020;9(3):641-656doi: 10.1007/s40121-020-00319-0.
Beeslaar, J., Absalon, J., Anderson, A. S., Eiden, J. J., Balmer, P., Harris, S. L., Jones, T. R., O'Neill, R. E., Pregaldien, J. L., Radley, D., Maansson, R., Ginis, J., Srivastava, A., & Perez, J. L. (2020). MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies. Infectious diseases and therapy, 9(3), 641-656. https://doi.org/10.1007/s40121-020-00319-0
Beeslaar, Johannes, et al. "MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies." Infectious diseases and therapy vol. 9,3 (2020): 641-656. doi: https://doi.org/10.1007/s40121-020-00319-0
Beeslaar J, Absalon J, Anderson AS, Eiden JJ, Balmer P, Harris SL, Jones TR, O'Neill RE, Pregaldien JL, Radley D, Maansson R, Ginis J, Srivastava A, Perez JL. MenB-FHbp Vaccine Protects Against Diverse Meningococcal Strains in Adolescents and Young Adults: Post Hoc Analysis of Two Phase 3 Studies. Infect Dis Ther. 2020 Sep;9(3):641-656. doi: 10.1007/s40121-020-00319-0. Epub 2020 Jul 22. PMID: 32700260; PMCID: PMC7452968.
Copy
Download .nbib